6Xue-Liang Jiang Department of Gastroenterology,Chinese PLA General Hospital of Jinan Command,Jinan 250031,China Hui-Fei Cui Department of Biochemical Pharmaceutics,Shandong University,Jinan 250012,Shandong Province,China.An analysis of 10218 ulcerative colitis cases in China[J].World Journal of Gastroenterology,2002,8(1):158-161. 被引量：217
4[2]Bouma G,Strober W.The immunological and genetic basis of inflammatory bowel disease[J].Nat Rev Immunol,2003,3(7):521-533.
5[5]Su C,Salzberg BA,Lewis JD,et al.Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis′[J].Am J Gastroenterol,2002,97(10):2577-2584.
6[7]Watanabe C,Miura S,Hokari R,et al.Spatial heterogeneity of TNF-α induced T cell migration to colonic mucosa is mediared by MAdCAM-1 and VCAM-1[J].Am J Physiol Gastrointest Liver Physiol,2002,283(1):G1379-G1387.
7[8]Sangfelt P,Carlson M,Thorn M,et al.Local release of human neutrophil lipocalin (HNL),IL-8,and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis[J].Dig Dis Sci,2002,47(9):2064-2069.
8[9]Guihot G,Guimbaud R,Bertrand V,et al.Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas:correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease[J].Amino Acids,2000,18(3):229-237.
9[10]Colon AL,Menchen LA,Hurtado O,et al.Implication of TNF-alpha convertase (TACE/ADAM17)in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis[J].Cytokine,2001,16(6):220-226.
